Skip to content

Adolescent Vaccination in Pharmacies

Building Evidence to Expand Adolescent Vaccination in Pharmacies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01960088
Acronym
AVIP
Enrollment
1509
Registered
2013-10-10
Start date
2015-07-31
Completion date
2018-04-30
Last updated
2018-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluating Attitudes Toward HPV Vaccinations in Pharmacies, Evaluating the Provision of HPV Vaccines in a Pharmacy

Keywords

Adolescent vaccines, HPV vaccine, Pharmacies

Brief summary

The study aims to expand the evidence supporting pharmacy provision of adolescent vaccines, including human papillomavirus (HPV) vaccine. In the first part of the study, we will characterize parents' attitudes and support for pharmacy provision of adolescent vaccines in a national survey. In the second part of the study, we will provide HPV vaccines and other vaccines (Tdap, meningococcal, varicella, influenza) to 200 adolescents in a local community pharmacy in Chapel Hill, North Carolina. This portion of the study will identify the systems and workflow needed to provide vaccines effectively and safely, characterize parents' and their adolescents' attitudes toward receiving vaccine services in a pharmacy, and characterize pharmacists' attitudes toward providing adolescent vaccine services in a pharmacy.

Interventions

DRUGHPV vaccine

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
11 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

NATIONAL SURVEY (probability sample) Inclusion Criteria: * Being a member of the GfK Knowledge Panel * Having a child age 11-18.

Exclusion criteria

● None PHARMACY DEMONSTRATION PROJECT (convenience sample) Inclusion Criteria: * Having an adolescent child, ages 11-18 years old, who is healthy, and for whom HPV vaccine is indicated * Child is with the parent

Design outcomes

Primary

MeasureTime frameDescription
Parents' willingness to get their adolescent children HPV vaccine in pharmacyAt time of studyOutcome is for the national survey of parents.
Parents' satisfaction with HPV vaccine vaccine administration in the pharmacyAt time of vaccine administrationOutcome is for demonstration study in a community pharmacy.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026